文献速递免疫规划传染病防控与疫情报告

巴西萨尔瓦多PCV10时代临床肺炎儿童的肺炎球菌携带与呼吸道病毒

Pneumococcal carriage and selected respiratory virus in children with clinical pneumonia in Salvador, Brazil during PCV10 era.
PubMed 文献 · Vaccine · 2026-10-14

在巴西萨尔瓦多PCV10成熟期,前瞻性纳入170名2-59月龄临床肺炎儿童,检测鼻咽肺炎球菌携带及呼吸道病毒。肺炎球菌携带率62.7%,PCV10血清型占10.4%;RSV检出率20.6%。下一代PCV可提供更广血清型覆盖,持续监测疫苗血清型循环仍重要。

要点

  • PCV10血清型仍可在肺炎患儿携带菌株中检出,占10.4%。
  • 携带菌株对下一代PCV血清型覆盖比例更高,20价达40.6%。
  • RSV检出率20.6%,其中60.0%合并肺炎球菌定植。

核心结论

  • PCV10引入十余年后,尽管疫苗接种率高,肺炎患儿携带的肺炎球菌中仍可检出PCV10血清型。
  • 下一代PCV可提供更广的血清型覆盖,持续监测疫苗血清型循环仍重要。

研究设计与样本

  • 前瞻性研究,纳入巴西萨尔瓦多两家急诊机构中2-59月龄符合标准化临床肺炎病例定义的儿童。
  • 鼻咽标本经培养和qPCR检测肺炎球菌,血清型经Quellung和/或PCR或qPCR确定,分离株行抗菌药物敏感性试验。
  • 呼吸道病毒用qPCR检测,RSV毒株进行基因分型。

主要发现

  • 2023年3月至2024年3月共纳入170名临床肺炎儿童,93.5%肺炎球菌疫苗接种及时。
  • 肺炎球菌携带率62.7%(106/169),其中培养阳性55例、qPCR阳性51例。
  • 106株携带菌株中最常见血清型为6C(18.9%)、11A/D(9.4%)、19A(7.5%)、3(6.6%)、19F(5.7%)、6A(5.0%)、23B(4.7%)。
  • PCV10血清型(19F、4、7F/A、9V/A、23F)占10.4%(11/106),主要由19F驱动(5.6%)。
  • 携带菌株含PNEUMOSIL、13价、15价、20价血清型的比例分别为21.7%、29.2%、30.2%、40.6%;53株行药敏试验中,>30.0%对大环内酯类耐药,35.8%对青霉素非敏感。

临床怎么用

  • 在PCV10高接种率地区,临床肺炎患儿仍可能携带疫苗血清型肺炎球菌,应结合当地血清型监测评估疫苗选择。
  • 下一代PCV可覆盖更多携带血清型,但需持续监测疫苗血清型持续循环及抗菌药物耐药情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In 2010, Brazil introduced the 10-valent pneumococcal conjugate vaccine (PCV10GSK). Assessing pneumococcal carriage among children with clinical pneumonia in the context of a mature PCV10GSK program can inform decisions about use of next-generation PCVs. METHODS: We prospectively enrolled children aged 2-59 months meeting a standardized case definition for clinical pneumonia at two emergency care units in Salvador, Brazil. Nasopharyngeal specimens were tested for pneumococcus by culture and qPCR with serotyping by Quellung and/or PCR or qPCR; isolates underwent antimicrobial susceptibility testing (AST). Respiratory viruses were detected using qPCR, and respiratory syncytial virus (RSV) strains were genotyped. RESULTS: From March 2023 to March 2024, 170 children with clinical pneumonia were enrolled; 93.5% were up to date on pneumococcal vaccination. Pneumococcal carriage was detected in 62.7% (106/169 swabbed patients; 55 by culture and 51 by qPCR). Among the 106 pneumococcal carriers, the most prevalent serotypes were 6C (18.9%), 11A/D (9.4%), 19A (7.5%), 3 (6.6%), 19F (5.7%), 6A (5.0%), and 23B (4.7%). PCV10GSK serotypes (19F, 4, 7F/A, 9V/A, 23F) were detected in 10.4% (11/106) of pneumococcal isolates, driven by serotype 19F (5.6%). The proportions of carriers with serotypes including in PNEUMOSIL, 13, 15, and 20 serotypes, were 21.7%, 29.2%, 30.2%, and 40.6%, respectively. Among 53 isolates with AST, more than 30.0% were resistant to macrolides and 35.8% were penicillin non-susceptible. RSV was detected in 20.6% (35/170) of cases, predominantly RSV-A (72.0%); 60.0% of RSV-positive cases were colonized with pneumococcus. CONCLUSION: More than a decade after PCV10GSK introduction, and despite high vaccination coverage, PCV10GSK serotypes remain detectable among pneumococci carried by children with pneumonia. Next-generation PCVs provide broader serotype coverage. Continued monitoring of the persistent circulation of vaccine serotypes remains important.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Menezes APO, Leite JLP, Pimenta FC, et al. Pneumococcal carriage and selected respiratory virus in children with clinical pneumonia in Salvador, Brazil during PCV10 era. Vaccine. 2026. PMID: 42874154. doi:10.1016/j.vaccine.2026.129241

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。